OTC Pharmaceuticals in Taiwan
Published: August 2013 · Publisher: MarketLine
OTC Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017).
- Description
- Companies Mentioned
- Table of Contents
- Ask a Question
Introduction
OTC Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Taiwan otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.
*The Taiwanese OTC pharmaceuticals market had total revenues of $1,598.7m in 2012, representing a compound annual growth rate (CAGR) of 5.5% between 2008 and 2012.
*The traditional medicines segment was the market's most lucrative in 2012, with total revenues of $823.6m, equivalent to 51.5% of the market's overall value
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.2% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $1,968.4m by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Taiwan
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Taiwan
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Taiwan otc pharmaceuticals market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the Taiwan economy
Key Questions Answered
What was the size of the Taiwan otc pharmaceuticals market by value in 2012?
What will be the size of the Taiwan otc pharmaceuticals market in 2017?
What factors are affecting the strength of competition in the Taiwan otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Taiwan's otc pharmaceuticals market?
OTC Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Taiwan otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.
*The Taiwanese OTC pharmaceuticals market had total revenues of $1,598.7m in 2012, representing a compound annual growth rate (CAGR) of 5.5% between 2008 and 2012.
*The traditional medicines segment was the market's most lucrative in 2012, with total revenues of $823.6m, equivalent to 51.5% of the market's overall value
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.2% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $1,968.4m by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Taiwan
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Taiwan
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Taiwan otc pharmaceuticals market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the Taiwan economy
Key Questions Answered
What was the size of the Taiwan otc pharmaceuticals market by value in 2012?
What will be the size of the Taiwan otc pharmaceuticals market in 2017?
What factors are affecting the strength of competition in the Taiwan otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Taiwan's otc pharmaceuticals market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
China Chemical & Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Johnson & Johnson and Sinphar Pharmaceutical Co., Ltd
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market share 11
Market distribution 12
Market Outlook 13
Market value forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
China Chemical & Pharmaceutical Co., Ltd. 20
Daiichi Sankyo Co., Ltd. 23
Johnson & Johnson 26
Sinphar Pharmaceutical Co., Ltd 29
Macroeconomic Indicators 32
Country Data 32
Appendix 34
Methodology 34
Industry associations 35
Related research 35
LIST OF TABLES
Table 1: Taiwan OTC pharmaceuticals market value: $ million, 2008–12 8
Table 2: Taiwan OTC pharmaceuticals market category segmentation: $ million, 2012 9
Table 3: Taiwan OTC pharmaceuticals market geography segmentation: $ million, 2012 10
Table 4: Taiwan OTC pharmaceuticals market share: % share, by value, 2012 11
Table 5: Taiwan OTC pharmaceuticals market distribution: % share, by value, 2012 12
Table 6: Taiwan OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Table 7: China Chemical & Pharmaceutical Co., Ltd.: key facts 20
Table 8: China Chemical & Pharmaceutical Co., Ltd.: key financials ($) 20
Table 9: China Chemical & Pharmaceutical Co., Ltd.: key financials (NT$) 21
Table 10: China Chemical & Pharmaceutical Co., Ltd.: key financial ratios 21
Table 11: Daiichi Sankyo Co., Ltd.: key facts 23
Table 12: Daiichi Sankyo Co., Ltd.: key financials ($) 23
Table 13: Daiichi Sankyo Co., Ltd.: key financials (¥) 24
Table 14: Daiichi Sankyo Co., Ltd.: key financial ratios 24
Table 15: Johnson & Johnson: key facts 26
Table 16: Johnson & Johnson: key financials ($) 27
Table 17: Johnson & Johnson: key financial ratios 27
Table 18: Sinphar Pharmaceutical Co., Ltd: key facts 29
Table 19: Sinphar Pharmaceutical Co., Ltd: key financials ($) 29
Table 20: Sinphar Pharmaceutical Co., Ltd: key financials (NT$) 30
Table 21: Sinphar Pharmaceutical Co., Ltd: key financial ratios 30
Table 22: Taiwan size of population (million), 2008–12 32
Table 23: Taiwan gdp (constant 2000 prices, $ billion), 2008–12 32
Table 24: Taiwan gdp (current prices, $ billion), 2008–12 32
Table 25: Taiwan inflation, 2008–12 33
Table 26: Taiwan consumer price index (absolute), 2008–12 33
Table 27: Taiwan exchange rate, 2008–12 33
LIST OF FIGURES
Figure 1: Taiwan OTC pharmaceuticals market value: $ million, 2008–12 8
Figure 2: Taiwan OTC pharmaceuticals market category segmentation: % share, by value, 2012 9
Figure 3: Taiwan OTC pharmaceuticals market geography segmentation: % share, by value, 2012 10
Figure 4: Taiwan OTC pharmaceuticals market share: % share, by value, 2012 11
Figure 5: Taiwan OTC pharmaceuticals market distribution: % share, by value, 2012 12
Figure 6: Taiwan OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Taiwan, 2012 14
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Taiwan, 2012 15
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Taiwan, 2012 16
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Taiwan, 2012 17
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Taiwan, 2012 18
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Taiwan, 2012 19
Figure 13: China Chemical & Pharmaceutical Co., Ltd.: revenues & profitability 21
Figure 14: China Chemical & Pharmaceutical Co., Ltd.: assets & liabilities 22
Figure 15: Daiichi Sankyo Co., Ltd.: revenues & profitability 24
Figure 16: Daiichi Sankyo Co., Ltd.: assets & liabilities 25
Figure 17: Johnson & Johnson: revenues & profitability 27
Figure 18: Johnson & Johnson: assets & liabilities 28
Figure 19: Sinphar Pharmaceutical Co., Ltd: revenues & profitability 30
Figure 20: Sinphar Pharmaceutical Co., Ltd: assets & liabilities 31
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market share 11
Market distribution 12
Market Outlook 13
Market value forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
China Chemical & Pharmaceutical Co., Ltd. 20
Daiichi Sankyo Co., Ltd. 23
Johnson & Johnson 26
Sinphar Pharmaceutical Co., Ltd 29
Macroeconomic Indicators 32
Country Data 32
Appendix 34
Methodology 34
Industry associations 35
Related research 35
LIST OF TABLES
Table 1: Taiwan OTC pharmaceuticals market value: $ million, 2008–12 8
Table 2: Taiwan OTC pharmaceuticals market category segmentation: $ million, 2012 9
Table 3: Taiwan OTC pharmaceuticals market geography segmentation: $ million, 2012 10
Table 4: Taiwan OTC pharmaceuticals market share: % share, by value, 2012 11
Table 5: Taiwan OTC pharmaceuticals market distribution: % share, by value, 2012 12
Table 6: Taiwan OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Table 7: China Chemical & Pharmaceutical Co., Ltd.: key facts 20
Table 8: China Chemical & Pharmaceutical Co., Ltd.: key financials ($) 20
Table 9: China Chemical & Pharmaceutical Co., Ltd.: key financials (NT$) 21
Table 10: China Chemical & Pharmaceutical Co., Ltd.: key financial ratios 21
Table 11: Daiichi Sankyo Co., Ltd.: key facts 23
Table 12: Daiichi Sankyo Co., Ltd.: key financials ($) 23
Table 13: Daiichi Sankyo Co., Ltd.: key financials (¥) 24
Table 14: Daiichi Sankyo Co., Ltd.: key financial ratios 24
Table 15: Johnson & Johnson: key facts 26
Table 16: Johnson & Johnson: key financials ($) 27
Table 17: Johnson & Johnson: key financial ratios 27
Table 18: Sinphar Pharmaceutical Co., Ltd: key facts 29
Table 19: Sinphar Pharmaceutical Co., Ltd: key financials ($) 29
Table 20: Sinphar Pharmaceutical Co., Ltd: key financials (NT$) 30
Table 21: Sinphar Pharmaceutical Co., Ltd: key financial ratios 30
Table 22: Taiwan size of population (million), 2008–12 32
Table 23: Taiwan gdp (constant 2000 prices, $ billion), 2008–12 32
Table 24: Taiwan gdp (current prices, $ billion), 2008–12 32
Table 25: Taiwan inflation, 2008–12 33
Table 26: Taiwan consumer price index (absolute), 2008–12 33
Table 27: Taiwan exchange rate, 2008–12 33
LIST OF FIGURES
Figure 1: Taiwan OTC pharmaceuticals market value: $ million, 2008–12 8
Figure 2: Taiwan OTC pharmaceuticals market category segmentation: % share, by value, 2012 9
Figure 3: Taiwan OTC pharmaceuticals market geography segmentation: % share, by value, 2012 10
Figure 4: Taiwan OTC pharmaceuticals market share: % share, by value, 2012 11
Figure 5: Taiwan OTC pharmaceuticals market distribution: % share, by value, 2012 12
Figure 6: Taiwan OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Taiwan, 2012 14
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Taiwan, 2012 15
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Taiwan, 2012 16
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Taiwan, 2012 17
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Taiwan, 2012 18
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Taiwan, 2012 19
Figure 13: China Chemical & Pharmaceutical Co., Ltd.: revenues & profitability 21
Figure 14: China Chemical & Pharmaceutical Co., Ltd.: assets & liabilities 22
Figure 15: Daiichi Sankyo Co., Ltd.: revenues & profitability 24
Figure 16: Daiichi Sankyo Co., Ltd.: assets & liabilities 25
Figure 17: Johnson & Johnson: revenues & profitability 27
Figure 18: Johnson & Johnson: assets & liabilities 28
Figure 19: Sinphar Pharmaceutical Co., Ltd: revenues & profitability 30
Figure 20: Sinphar Pharmaceutical Co., Ltd: assets & liabilities 31
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.